Hangzhou Chance Pharmaceuticals Expands Pipeline with In-Licensing of AER901 from Aerami Therapeutics
Hangzhou, China, February 9 2021 (GLOBE Newswire) — Hangzhou Chance Pharmaceuticals (“Chance”), a cl...
Chance Pharmaceutical was recognized as a small and medium-sized science and technology enterprise
According to the "Notice of Zhejiang Provincial Department of Science and Technology on Printing and...
The Chance Table Tennis League is starting
On January 7, 2021, at 4:50 pm, the Chance Table Tennis League officially kicked off. After registra...
On Christmas Eve, we prepared a peace fruit in advance for everyone, put our best wishes into the bo...
Chance Pharmaceuticals completes 80 million RMB in Series B financing
Chance Pharmaceuticals a domestic platform company focused on inhaled drug delivery systems, announc...